Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Eat Well Investment Group Names New CFO Following Patrick Dunn's Resignation

Eat Well Investment Group Names New CFO Following Patrick Dunn's Resignation

MT newswireMT newswire2026/10/20 20:25
04:25 PM EDT, 10/20/2026 (MT Newswires) -- Eat Well Investment Group (EWG.CN) after trade Tuesday said Patrick Dunn has resigned as chief financial officer and director. Matthew Anderson was appointed CFO, which came into effect Oct. 16, with Dunn assisting in the transition to ensure continuity, the company added. Anderson has over 20 years of accounting and CFO experience and is a managing director at Malaspina Consultants. It is a Vancouver-based firm that has supported Eat Well's accounting and financial reporting since July 2025, the company said. "Following Dunn's resignation, the Board consists of Daniel Brody, Desmond Balakrishnan and Nick Grafton," the company added. Shares of Eat Well Investment Group were unchanged at CA$0.08 on the Canadian Securities Exchange.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment

According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.

智通财经•2026/11/06 08:27

GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions

Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.

智通财经•2026/11/06 07:56

Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.

After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.

智通财经•2026/11/06 07:53